W STRATEGIES, LLC

Lobbying for ASTRAZENECA PHARMACEUTICALS LP · Biopharmaceutical Company.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · Delaware · House · Senate · $80,000.00 income · posted Apr 20, 2026

Bills named in this filing 1

Lobbying activity 1

Medicare/Medicaid

Issues around drug pricing. Public Law 119-21: One Big Beautiful Bill Act, as it relates to H.R.946 - Orphan Cures Act. Education about 340b program.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.